139 related articles for article (PubMed ID: 31299146)
1. Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of
Madani A; Ridenour JN; Martin BP; Paudel RR; Abdul Basir A; Le Moigne V; Herrmann JL; Audebert S; Camoin L; Kremer L; Spilling CD; Canaan S; Cavalier JF
ACS Infect Dis; 2019 Sep; 5(9):1597-1608. PubMed ID: 31299146
[TBL] [Abstract][Full Text] [Related]
2. Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases.
Nguyen PC; Madani A; Santucci P; Martin BP; Paudel RR; Delattre S; Herrmann JL; Spilling CD; Kremer L; Canaan S; Cavalier JF
Int J Antimicrob Agents; 2018 Apr; 51(4):651-654. PubMed ID: 29241819
[TBL] [Abstract][Full Text] [Related]
3. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the antibacterial activity of oxadiazolone-core derivatives against Mycobacterium abscessus.
Madani A; Mallick I; Guy A; Crauste C; Durand T; Fourquet P; Audebert S; Camoin L; Canaan S; Cavalier JF
PLoS One; 2020; 15(9):e0238178. PubMed ID: 32946441
[TBL] [Abstract][Full Text] [Related]
5. Cyclipostins and Cyclophostin analogs as promising compounds in the fight against tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Martin BP; Paudel R; Gnawali GR; Madani A; Puppo R; Landry V; Kremer L; Brodin P; Spilling CD; Cavalier JF; Canaan S
Sci Rep; 2017 Sep; 7(1):11751. PubMed ID: 28924204
[TBL] [Abstract][Full Text] [Related]
6. Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.
Cavalier JF; Spilling CD; Durand T; Camoin L; Canaan S
Eur J Med Chem; 2021 Jan; 209():112908. PubMed ID: 33071055
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis.
Nguyen PC; Nguyen VS; Martin BP; Fourquet P; Camoin L; Spilling CD; Cavalier JF; Cambillau C; Canaan S
J Mol Biol; 2018 Dec; 430(24):5120-5136. PubMed ID: 30292819
[TBL] [Abstract][Full Text] [Related]
8. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.
Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF
Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the intracellular activity of drugs against Mycobacterium abscessus using a THP-1 macrophage model.
Molina-Torres CA; Tamez-Peña L; Castro-Garza J; Ocampo-Candiani J; Vera-Cabrera L
J Microbiol Methods; 2018 May; 148():29-32. PubMed ID: 29626567
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of Long-Chain β-Lactones and Their Antibacterial Activities against Pathogenic Mycobacteria.
Santucci P; Dedaki C; Athanasoulis A; Gallorini L; Munoz A; Canaan S; Cavalier JF; Magrioti V
ChemMedChem; 2019 Feb; 14(3):349-358. PubMed ID: 30600911
[TBL] [Abstract][Full Text] [Related]
11. The MspA porin promotes growth and increases antibiotic susceptibility of both Mycobacterium bovis BCG and Mycobacterium tuberculosis.
Mailaender C; Reiling N; Engelhardt H; Bossmann S; Ehlers S; Niederweis M
Microbiology (Reading); 2004 Apr; 150(Pt 4):853-864. PubMed ID: 15073295
[TBL] [Abstract][Full Text] [Related]
12. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
Pryjma M; Burian J; Thompson CJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
[No Abstract] [Full Text] [Related]
13. Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens.
Cho EH; Huh HJ; Song DJ; Lee SH; Kim CK; Shin SY; Ki CS; Jhun BW; Moon SM; Kwon OJ; Koh WJ; Lee NY
Diagn Microbiol Infect Dis; 2019 Feb; 93(2):107-111. PubMed ID: 30236529
[TBL] [Abstract][Full Text] [Related]
14. Rational design of drug-like compounds targeting Mycobacterium marinum MelF protein.
Dharra R; Talwar S; Singh Y; Gupta R; Cirillo JD; Pandey AK; Kulharia M; Mehta PK
PLoS One; 2017; 12(9):e0183060. PubMed ID: 28873466
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Characterization of Fluorescent Cyclipostins and Cyclophostin Analogues: New Insights for the Diagnosis of Mycobacterial-Related Diseases.
Sarrazin M; Martin BP; Avellan R; Gnawali GR; Poncin I; Le Guenno H; Spilling CD; Cavalier JF; Canaan S
ACS Infect Dis; 2022 Dec; 8(12):2564-2578. PubMed ID: 36379042
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
17. Interaction of South Asian spices with conventional antibiotics: Implications for antimicrobial resistance for
Moore RE; Millar BC; Panickar JR; Moore JE
Int J Mycobacteriol; 2018; 7(3):257-260. PubMed ID: 30198506
[TBL] [Abstract][Full Text] [Related]
18. Evidence for Inhibition of Topoisomerase 1A by Gold(III) Macrocycles and Chelates Targeting Mycobacterium tuberculosis and Mycobacterium abscessus.
Gupta R; Rodrigues Felix C; Akerman MP; Akerman KJ; Slabber CA; Wang W; Adams J; Shaw LN; Tse-Dinh YC; Munro OQ; Rohde KH
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483110
[No Abstract] [Full Text] [Related]
19.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
20. Rifamycin O, An Alternative Anti-
Hanh BTB; Park JW; Kim TH; Kim JS; Yang CS; Jang K; Cui J; Oh DC; Jang J
Molecules; 2020 Mar; 25(7):. PubMed ID: 32244387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
